José Baselga

6PUBLICATIONS
68CO-AUTHORS
Haematological tumoursGlobal and planetary environmental engineeringMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 07, 2020
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19.

Mark Roschewski, Michail S Lionakis, Jeff P Sharman

|Jan 15, 2020
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.

Guotai Xu, Sagar Chhangawala, Emiliano Cocco

|Nov 09, 2019
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.

Neil Vasan, Pedram Razavi, Jared L Johnson

|Oct 11, 2018
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).

Emiliano Cocco, F Javier Carmona, Pedram Razavi

|Oct 05, 2018
p95HER2-T cell bispecific antibody for breast cancer treatment.

Irene Rius Ruiz, Rocio Vicario, Beatriz Morancho

|Mar 25, 2017
PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D.

Eneda Toska, Hatice U Osmanbeyoglu, Pau Castel

Pageof 1